Providence Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

Providence Wealth Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$42.4K	–	98
2023 Q1	$42.4K	Hold	10,000	–	–	0.03%	93
2022 Q4	$44K	Hold	10,000	–	–	0.03%	93
2022 Q3	$55K	Hold	10,000	–	–	0.04%	95
2022 Q2	$51K	Hold	10,000	–	–	0.04%	96
2022 Q1	$51K	Hold	10,000	–	–	0.03%	99
2021 Q4	$67K	Hold	10,000	–	–	0.04%	97
2021 Q3	$57K	Hold	10,000	–	–	0.04%	95
2021 Q2	$63K	Sell	10,000 -2,500	-20%	-$17.4K	0.04%	96
2021 Q1	$101K	Sell	12,500 -500	-4%	-$4.08K	0.07%	92
2020 Q4	$87K	Buy	13,000 +250	+2%	+$1.46K	0.07%	91
2020 Q3	$46K	Sell	12,750 -500	-4%	-$2.02K	0.05%	86
2020 Q2	$61K	Buy	13,250 +2,000	+18%	+$8.51K	0.06%	86
2020 Q1	$39K	Buy	+11,250	New	+$49.2K	0.05%	84

Other funds holding IMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Providence Wealth Advisors's IMGN Position: Q2 2023 in Review

Providence Wealth Advisors sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 10,000 shares — an estimated $42.4K sold.

Providence Wealth Advisors first reported a position in IMGN in Q1 2020 and held it in 13 quarters. The position peaked at $101K in Q1 2021. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

Providence Wealth Advisors reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
Providence Wealth Advisors sold 10,000 Immunogen Inc shares in Q2 2023, an estimated $42.4K.
Providence Wealth Advisors first reported a position in Immunogen Inc in Q1 2020 and held it in 13 quarters.
Providence Wealth Advisors's Immunogen Inc position peaked at $101K in Q1 2021.
266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Providence Wealth Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.